Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

AHBARx vs Oak

AHBARx
Site position #270

Higher grade

Oak
Site position #221

Lower grade

The verdict

AHBARx takes it — 64.2/100 to 63.2/100, but only just.

AHBARx grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. AHBARx prices semaglutide and tirzepatide openly before any intake, names its founder as a physician, and leaves its own legal pages half-written. Oak is close behind and may still be the better fit — see the factor split below.

We may earn a commission through these links, at no extra cost to you. Commercial relationships affect placement, but never the WeighScore or our editorial findings. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueOak +11
47
58
Dose & formulationAHBARx +2
64
62
Clinical oversightAHBARx +5
71
66
Labs & monitoringAHBARx +4
62
58
FulfillmentAHBARx +2
90
88
Contract termsAHBARx +19
67
48
AHBARx · top barOak · bottom bar

The numbers

Swipe or scroll to compare both providers.

MetricAHBARxOak
WeighScore64.2/10063.2/100
GradeCC
Site position#270#221
Semaglutide$249/mo (1-month supply; consult and shipping included)$250/mo (one flat rate at every dose), read on its order form the afternoon of 15 August; it showed $200/mo that morning
Tirzepatide$349/mo (1-month supply; consult and shipping included)$300/mo (one flat rate at every dose), read on its order form the afternoon of 15 August; it showed $250/mo that morning
CoverageAll 50 statesAll 50 states
Brand-name accessNot confirmedNot confirmed
Oral / sublingualNot confirmedNot confirmed
AHBARx

Site position #270 · C

Strengths

  • Both molecule prices sit on the product pages with no quiz, no account and no email step in front of them
  • The figure is described as covering the consult and shipping, and checkout shows one line rather than a medication charge plus a membership charge
  • Names a founding physician, Dr. Nima Yazdanpanah, DO, and names its partner organizations in the Help Center — most of the field names neither
  • Refills are reviewed at a follow-up consultation rather than shipped on a timer

What to consider

  • The Terms and Privacy pages are unfinished templates: they still carry the literal placeholders [www.ahbarx.com], [list of Pharmacies] and [phone number], and name no legal entity
  • The About page says there are no membership fees while the Terms require a Weight Loss Membership on an automatically renewing monthly subscription
  • A 35% welcome code is applied to the first order and the site never states what the second order costs
  • The footer claims all 50 states, the Privacy page says service is limited to certain states, and no list is published
  • AnazaoHealth, named in the Help Center as a partner, is the subject of an FDA warning letter issued August 2021 to “AnazaoHealth Corporation” of Las Vegas, Nevada. It is a disclosure about a supplier; AHBARx carries no warning letter of its own
  • No compounding class is stated anywhere, so whether the medication is compounded under 503A or 503B is unknown
Oak

Site position #221 · C

Strengths

  • No membership or subscription fee, and free shipping
  • All 50 states, offered in Spanish as well as English
  • One price at every dose, so titrating up does not cost more — its order form states it as "One price · All dosages" beside the figure itself
  • The price is reachable without handing over any medical detail: the figures sit on the first screen of its order form, before a single question is answered

What to consider

  • Its advertising and its order form disagree: none of the nine "starting" figures it markets is the $200/$250 it actually charges, so anyone comparing on the advertised numbers is comparing against a price Oak does not offer
  • Nine conflicting "starting" figures appear across Oak's own pages — $119, $133, $160, $167, $180, $185, $190, $199 and $250 — and none carries a term or a billing cadence. Its headline "$133 / $199" is the three-month prepay under code OAKSAVE200, billed upfront, not a monthly rate
  • The cheapest two, "$119" and "$185", sit beside a "$200 off" new-patient offer that Oak elsewhere describes as "$50 off your first month, $200 off 3-months" — a three-month package discount, not a monthly rate
  • Its two comparison tables disagree with each other and with its two FAQs: $167/mo against $190/mo, "as little as $119/month" against "as little as $190/month or lower"
  • Worth re-checking at the last step: an earlier reading of its checkout copy recorded dose steps costing roughly $50–$75 more, which its order form's "One price · All dosages" line contradicts
  • Same-day approval with no video call means very little clinical contact before a prescription
  • No published lab or monitoring program
  • Injection only, and no brand-name lane
  • Sold as packages, so re-ordering is on you

Featured provider

Oak

Oak scores 63.2/100 (C). Charges $200/mo for compounded semaglutide and $250 for tirzepatide, one flat rate at every dose — but you will not find those figures in its advertising, where nine different "starting" prices appear across its own pages and not one of them is what it charges.

Commercial relationships affect this placement. The score comparison above is separate.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard